Literature DB >> 24099080

On the histone lysine methyltransferase activity of fungal metabolite chaetocin.

Fanny L Cherblanc1, Kathryn L Chapman, Jim Reid, Aaron J Borg, Sandeep Sundriyal, Laura Alcazar-Fuoli, Elaine Bignell, Marina Demetriades, Christopher J Schofield, Peter A DiMaggio, Robert Brown, Matthew J Fuchter.   

Abstract

Histone lysine methyltransferases (HKMTs) are an important class of targets for epigenetic therapy. 1 (chaetocin), an epidithiodiketopiperazine (ETP) natural product, has been reported to be a specific inhibitor of the SU(VAR)3-9 class of HKMTs. We have studied the inhibition of the HKMT G9a by 1 and functionally related analogues. Our results reveal that only the structurally unique ETP core is required for inhibition, and such inhibition is time-dependent and irreversible (in the absence of DTT), ultimately resulting in protein denaturation. Mass spectrometric data provide a molecular basis for this effect, demonstrating covalent adduct formation between 1 and the protein. This provides a potential rationale for the selectivity observed in the inhibition of a variety of HKMTs by 1 in vitro and has implications for the activity of ETPs against these important epigenetic targets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24099080     DOI: 10.1021/jm401063r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

Review 1.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

Review 2.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

3.  High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.

Authors:  Nathan P Coussens; Stephen C Kales; Mark J Henderson; Olivia W Lee; Kurumi Y Horiuchi; Yuren Wang; Qing Chen; Ekaterina Kuznetsova; Jianghong Wu; Sirisha Chakka; Dorian M Cheff; Ken Chih-Chien Cheng; Paul Shinn; Kyle R Brimacombe; Min Shen; Anton Simeonov; Madhu Lal-Nag; Haiching Ma; Ajit Jadhav; Matthew D Hall
Journal:  J Biol Chem       Date:  2018-06-26       Impact factor: 5.157

4.  Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia.

Authors:  Sophie Schweizer; Christoph Harms; Heike Lerch; Jennifer Flynn; Jochen Hecht; Ferah Yildirim; Andreas Meisel; Stefanie Märschenz
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

5.  Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells through alternative splicing of c-Mpl.

Authors:  Nan Xiao; Suparna Laha; Shankar P Das; Kayla Morlock; Jonathan L Jesneck; Glen D Raffel
Journal:  Blood       Date:  2014-12-02       Impact factor: 22.113

6.  Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex.

Authors:  Pamela Prini; Franceso Rusconi; Erica Zamberletti; Marina Gabaglio; Federica Penna; Mauro Fasano; Elena Battaglioli; Daniela Parolaro; Tiziana Rubino
Journal:  J Psychiatry Neurosci       Date:  2017-10-12       Impact factor: 6.186

7.  The promise and peril of chemical probes.

Authors:  Cheryl H Arrowsmith; James E Audia; Christopher Austin; Jonathan Baell; Jonathan Bennett; Julian Blagg; Chas Bountra; Paul E Brennan; Peter J Brown; Mark E Bunnage; Carolyn Buser-Doepner; Robert M Campbell; Adrian J Carter; Philip Cohen; Robert A Copeland; Ben Cravatt; Jayme L Dahlin; Dashyant Dhanak; Aled M Edwards; Mathias Frederiksen; Stephen V Frye; Nathanael Gray; Charles E Grimshaw; David Hepworth; Trevor Howe; Kilian V M Huber; Jian Jin; Stefan Knapp; Joanne D Kotz; Ryan G Kruger; Derek Lowe; Mary M Mader; Brian Marsden; Anke Mueller-Fahrnow; Susanne Müller; Ronan C O'Hagan; John P Overington; Dafydd R Owen; Saul H Rosenberg; Bryan Roth; Brian Roth; Ruth Ross; Matthieu Schapira; Stuart L Schreiber; Brian Shoichet; Michael Sundström; Giulio Superti-Furga; Jack Taunton; Leticia Toledo-Sherman; Chris Walpole; Michael A Walters; Timothy M Willson; Paul Workman; Robert N Young; William J Zuercher
Journal:  Nat Chem Biol       Date:  2015-08       Impact factor: 15.040

8.  Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II).

Authors:  Madura K P Jayatunga; Sam Thompson; Tawnya C McKee; Mun Chiang Chan; Kelie M Reece; Adam P Hardy; Rok Sekirnik; Peter T Seden; Kristina M Cook; James B McMahon; William D Figg; Christopher J Schofield; Andrew D Hamilton
Journal:  Eur J Med Chem       Date:  2014-06-27       Impact factor: 6.514

9.  The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells.

Authors:  Y-S Lai; J-Y Chen; H-J Tsai; T-Y Chen; W-C Hung
Journal:  Blood Cancer J       Date:  2015-05-15       Impact factor: 11.037

10.  Tricyclic Analogues of Epidithiodioxopiperazine Alkaloids with Promising In Vitro and In Vivo Antitumor Activity.

Authors:  Marcus Baumann; André P Dieskau; Brad M Loertscher; Mary C Walton; Sangkil Nam; Jun Xie; David Horne; Larry E Overman
Journal:  Chem Sci       Date:  2015       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.